These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12823742)

  • 1. Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period.
    Aprili G; Gandini G; Piccoli P; Bressan F; De Gironcoli M; Mazzi R; Parisi SG; Gessoni G; Marchiori G; Franchini M
    Transfusion; 2003 Jul; 43(7):848-52. PubMed ID: 12823742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
    Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
    JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV transmissions from a window-period platelet donation.
    Kopko PM; Fernando LP; Bonney EN; Freeman JL; Holland PV
    Am J Clin Pathol; 2001 Oct; 116(4):562-6. PubMed ID: 11601141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
    Roth WK; Weber M; Buhr S; Drosten C; Weichert W; Sireis W; Hedges D; Seifried E
    Transfusion; 2002 Jul; 42(7):862-8. PubMed ID: 12375658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure and success of HIV tests for the prevention of HIV-1 transmission by blood and tissue donations.
    Najioullah F; Barlet V; Renaudier P; Guitton C; Crova P; Guérin JC; Peyramond D; Trabaud MA; Coudurier N; Tardy JC; André P
    J Med Virol; 2004 Jul; 73(3):347-9. PubMed ID: 15170627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
    Busch MP; Lee LL; Satten GA; Henrard DR; Farzadegan H; Nelson KE; Read S; Dodd RY; Petersen LR
    Transfusion; 1995 Feb; 35(2):91-7. PubMed ID: 7825218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 NAT minipool during the pre-seroconversion window period: detection of a repeat blood donor.
    Palla P; Vatteroni ML; Vacri L; Maggi F; Baicchi U
    Vox Sang; 2006 Jan; 90(1):59-62. PubMed ID: 16359357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
    Bruhn R; Lelie N; Custer B; Busch M; Kleinman S;
    Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.
    Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Fickett T; Busch M; Lelie N
    Transfusion; 2013 Oct; 53(10 Pt 2):2384-98. PubMed ID: 23445273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test-seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Busch MP; Williams AE
    Transfusion; 1996 Mar; 36(3):203-8. PubMed ID: 8604502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
    Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
    Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of unreported HIV prophylaxis on the kinetics of post-blood donation HIV seroconversion.
    Nishiya AS; Salles NA; de Almeida-Neto C; Witkin SS; Ferreira SC; Nogueira FAH; Facincani T; Rocha V; Mendrone-Jr A
    Transfusion; 2021 Dec; 61(12):3488-3492. PubMed ID: 34617611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations.
    Jackson BR; Busch MP; Stramer SL; AuBuchon JP
    Transfusion; 2003 Jun; 43(6):721-9. PubMed ID: 12757522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
    Vargo J; Smith K; Knott C; Wang S; Fang C; McDonough S; Giachetti C; Caglioti S; Gammon R; Gilbert D; Jackson JB; Richards W; Stramer S; Mimms L
    Transfusion; 2002 Jul; 42(7):876-85. PubMed ID: 12375660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor.
    Toro C; Rodés B; Colino F; del Valle Flores M; Poveda E; de Mendoza C; Téllez MJ; Soriano V
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):447-8. PubMed ID: 12882652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.